Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v3-EN
Language English English
Date Updated 2019-09-25 2019-09-25
Drug Identification Number 02126656 02126656
Brand name CYTARABINE INJECTION CYTARABINE INJECTION
Common or Proper name CYTARABINE INJECTION CYTARABINE INJECTION
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients CYTARABINE CYTARABINE
Strength(s) 100MG 100MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRATHECAL INTRAVENOUS SUBCUTANEOUS INTRATHECAL INTRAVENOUS SUBCUTANEOUS
Packaging size 10mL vial 10mL vial
ATC code L01BC L01BC
ATC description ANTIMETABOLITES ANTIMETABOLITES
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2019-09-24 2019-09-24
Remaining supply date 2019-09-24 2019-09-24
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Information on remaining supply
Company comments 1mL and 20mL presentations remain available. 1mL and 20mL presentations remain available.
Health Canada comments